COO  Cooper Companies Inc. (The)




Health Care


Ophthalmic Goods

Market Cap.


Vuru Grade


Current Price

+0.24 (+0.15%)

Growth Price

Overvalued by 34.19%

Stability Price

Overvalued by 87.08%

Company Metrics

  • 27.12 P/E
  • 4.76 P/S
  • 2.97 P/B
  • 6.035 EPS
  • 8.09% Cash ROIC
  • 0.24 Cash Ratio
  • 0.06 / 0.04% Dividend
  • 482,048.00 Avg. Vol.
  • 7.913B Market Cap.

Company Description

The Cooper Companies, Inc., through its subsidiaries, develops, manufactures, and markets healthcare products serving the vision care and women's healthcare markets worldwide. It offers a range of soft contact lenses for the vision care market, such as toric lenses, which correct astigmatism; multifocal lenses for presbyopia; and spherical lenses that correct the common visual defects. The company...

Download 10 Years of Financial Statements:
Income Statement   Balance Sheet   Cash Flow


The Cooper Companies Acquires EndoSee for $44 Million - Analyst Blog
NASDAQ - Oct 9, 2014
The Cooper Companies Inc. ( COO ) revealed that its women's healthcare unit - CooperSurgical - has acquired EndoSee Corporation for approximately $44 million.
The Cooper Companies Sets New 12-Month High at $166.52 (COO)
Mideast Time - 6 hours ago
The Cooper Companies logo The Cooper Companies (NYSE:COO)'s share price reached a new 52-week high during mid-day trading on Friday , Analyst Ratings Network.
The Cooper Companies' Women's Healthcare Unit Acquires EndoSee
Benzinga - Oct 8, 2014
The Cooper Companies, Inc. (NYSE: COO) today announced that CooperSurgical, its women's healthcare unit, has acquired EndoSee Corporation, a developer of an office-based disposable hysteroscopy system.
The Cooper Companies Upgraded to "Outperform" at Zacks (COO)
sleekmoney - Oct 24, 2014
The Cooper Companies, Inc. logo Zacks upgraded shares of The Cooper Companies (NYSE:COO) from a neutral rating to an outperform rating in a research report sent to investors on Wednesday morning.
The Cooper Companies Raised to Outperform at Zacks (COO) - WKRB News
4 stocks display high gross margins: Texas Instruments (TXN), The Cooper ...
Investor Wired (press release) - 17 hours ago
The Cooper Companies, Inc. (NYSE:COO) has 0.40% insider ownership while its EPS ratio was 6.04. The company has 48.28 million shares outstanding while market capitalization of the company was $7.90 billion.
The Cooper Companies Earns "Neutral" Rating from JPMorgan Chase & Co ...
WKRB News - Oct 14, 2014
The Cooper Companies, Inc. logo The Cooper Companies (NYSE:COO)'s stock had its “neutral” rating reaffirmed by JPMorgan Chase & Co.
The Cooper Companies Given Consensus Rating of "Hold" by Analysts (NYSE ...
sleekmoney - Oct 5, 2014
The Cooper Companies, Inc is a global medical device company. The Company operates through two business units, CooperVision, Inc and CooperSurgical, Inc CooperVision is a global manufacturer providing products for contact lens wearers.
JPMorgan Chase & Co. Reaffirms Neutral Rating for The Cooper Companies ...
Watch List News (press release) - Oct 15, 2014
The Cooper Companies, Inc. logo The Cooper Companies (NYSE:COO)'s stock had its “neutral” rating reissued by research analysts at JPMorgan Chase & Co.
Institutional Investors have a large stake in these stocks: The Cooper ...
Investor Wired (press release) - Oct 24, 2014
The Cooper Companies, Inc. (NYSE:COO) has $7.54 billion in market value and its institutional ownership was 96.60%. The company has P/B ratio of 2.82 while its P/S ratio was 4.54.
Strong Track Record Of EPS Growth: The Cooper Companies, (COO ...
Investor Wired (press release) - Oct 22, 2014
The Cooper Companies, Inc. (NYSE:COO) has the market capitalization of $7.56 billion and the company maintained EPS growth in prior 5 years of 33.00%.